Near Space Labs
Series B in 2025
Near Space Labs is an aerial imagery and earth observation company based in the United States that specializes in providing high-quality geospatial information for various sectors. The company offers cloud-based delivery of fully processed images through its API, facilitating easy monitoring of assets across broad or specific areas. Near Space Labs supports businesses, government organizations, and partners by delivering actionable insights that enhance remote sensing capabilities. Its services are utilized in diverse fields, including insurance, utilities, infrastructure, conservation, smart cities, retail, energy, and disaster response. By monitoring construction progress and addressing issues such as pipeline leaks, vegetation encroachment, and weather-related damage, Near Space Labs enables clients to improve mobility, leisure, and urban planning.
Chef Robotics
Series A in 2025
Chef Robotics is a robotics and artificial intelligence company serving the food industry. The company was founded in 2019 and is headquartered in San Francisco, California.
Esperto Medical
Series A in 2024
Esperto Medical is a medical device company based in Irvine, California, focused on developing advanced wearable diagnostics for both hospital and remote patient monitoring. The company utilizes innovative resonance sonomanometry technology, which employs acoustic stimulation to provide continuous and noninvasive blood pressure measurements without the need for calibration. By enabling round-the-clock monitoring of vital signs, Esperto Medical’s devices aim to enhance accessibility to medical care through automation, allowing patients to effectively manage their health from home or within clinical settings.
Feno is a pioneering oral health company that aims to improve overall health by addressing oral health issues. It develops innovative, tech-driven products such as the 20-second Feno Smartbrush, an at-home oral scanner, and AI-powered digital oral health coaches. These solutions, which leverage advanced technologies and proprietary formulations, empower individuals to take control of their oral health, thereby potentially reducing the risk of systemic health conditions like heart disease, stroke, and diabetes.
Discure Technologies is focused on developing a minimally invasive, implantable bioelectronic device aimed at treating degenerative disc disease (DDD). The company employs a novel bioelectric technique that targets the root causes of DDD, facilitating the healing of damaged discs, alleviating pain, and restoring normal function for patients. Through its innovative approach, Discure seeks to provide effective solutions for individuals suffering from this debilitating condition.
Viome Life Sciences
Series D in 2024
Viome Life Sciences, established in 2016 and headquartered in Bellevue, Washington, specializes in providing comprehensive health insights through its proprietary at-home clinical-grade tests. The company analyzes RNA from stool samples, along with other bodily fluids, to determine the makeup of microbial communities, offering personalized recommendations for diet and lifestyle based on the results. Viome's services aim to empower individuals to track their microbiome health, mitochondrial health, cellular health, and biological age, ultimately aiding in the prevention and reversal of chronic diseases. The company operates as a subsidiary of BlueDot LLC and sells its products through distributors and online channels.
Openwater
Venture Round in 2024
Openwater is a medical technology startup founded in 2016 and based in San Francisco, California. The company specializes in developing advanced wearable devices that utilize novel optoelectronics to achieve MRI-like resolution for medical diagnostics and treatments. By employing LCDs with small pixels, Openwater's technology creates holographic images that reduce scattering, enabling physicians to visualize the inner workings of the body and brain at a cellular level. This innovation allows for precise diagnosis and targeted treatment of diseases by manipulating or destroying individual cells without damaging surrounding tissue. Openwater aims to revolutionize medical imaging and improve patient outcomes through its cutting-edge approach.
Immunis
Venture Round in 2024
Immunis is a private biotechnology company focused on addressing age and disease-related immune decline through innovative stem cell-derived therapies. The company specializes in utilizing human stem cells to create specific populations of cells that secrete therapeutic factors. This approach aims to enable healthcare professionals to enhance immune system development, modulation, and overall health in patients. By harnessing the potential of stem cell technology, Immunis seeks to offer novel treatment options that can improve immune function and combat the effects of aging and various diseases.
Holoclara
Series A in 2024
Holoclara is an immunotherapy company focused on providing innovative solutions for individuals suffering from autoimmune disorders. The company specializes in delivering nematode-derived molecules known for their therapeutic properties. By identifying and developing these molecules from various worm species, Holoclara aims to create safe, orally available therapeutics that can improve the quality of life for patients. Through its targeted approach, Holoclara seeks to bring relief and promote overall health and well-being for those affected by autoimmune conditions.
Lucidity
Seed Round in 2024
Lucidity is a multi-cloud storage management platform that optimizes storage across AWS, Azure, and Google Cloud. The platform automates cloud infrastructure management by dynamically adjusting block storage in real time, which eliminates downtime and enhances application performance. By streamlining storage operations, Lucidity enables enterprises to significantly reduce cloud costs by up to 70% while ensuring consistent and reliable performance. This approach allows clients to effectively manage their storage resources based on their data requirements, leading to improved operational efficiency and predictable performance.
Synadia Communications Inc. is a technology company based in Los Angeles, California, founded in 2017. It specializes in developing a global utility platform that connects digital systems, services, and devices. The company is known for its open-source messaging system, NATS.io, which supports cloud-native applications, microservices architectures, and Internet of Things (IoT) messaging. Synadia leads the development of NATS.io as a Cloud Native Computing Foundation (CNCF) project and offers a secure, globally available communications platform known as NGS, built on this technology. In addition to its core offerings, Synadia provides commercial support, consulting, non-recurring engineering (NRE) services, and training, enabling organizations to leverage its innovative solutions for modern distributed systems.
Gallant Therapeutics
Series A in 2024
Gallant Therapeutics is an animal health biotechnology company developing allogeneic, "off-the-shelf" stem cell therapies from their stem cell platform. Gallant is also the leading provider of non-invasive stem cell banking during the spay or neuter process, opening the door to novel regenerative medical treatments formerly unavailable for non-human family members. Clinical studies demonstrate stem cell therapies help pets with a multitude of ailments, including osteoarthritis, atopic dermatitis, chronic kidney disease, and chronic stomatitis, among others. Gallant's first product helps to save cats that would die of chronic gingivostomatitis, with a robust pipeline in development for companion animals.
Mighty Buildings
Series B in 2023
Mighty Buildings, Inc. is a San Francisco-based company founded in 2017 that specializes in the manufacture of 3D printed custom homes. Utilizing advanced construction technology, the company employs 3D printing, robotics, and automation to create modular homes that aim to disrupt the residential housing market. Mighty Buildings has developed a proprietary building material known as Light Stone Material (LSM), which mimics synthetic stone and provides advantages such as faster construction, zero waste, and improved thermal regulation compared to traditional materials like concrete, wood, or steel. The company's innovative approach focuses on producing prefabricated, environmentally friendly, and climate-resilient homes, thereby facilitating smart urban development and making housing more affordable.
Viome Life Sciences
Series C in 2023
Viome Life Sciences, established in 2016 and headquartered in Bellevue, Washington, specializes in providing comprehensive health insights through its proprietary at-home clinical-grade tests. The company analyzes RNA from stool samples, along with other bodily fluids, to determine the makeup of microbial communities, offering personalized recommendations for diet and lifestyle based on the results. Viome's services aim to empower individuals to track their microbiome health, mitochondrial health, cellular health, and biological age, ultimately aiding in the prevention and reversal of chronic diseases. The company operates as a subsidiary of BlueDot LLC and sells its products through distributors and online channels.
Solarea Bio
Series B in 2023
Solarea Bio, Inc. is a biotechnology company based in Cambridge, Massachusetts, focused on developing microbial therapeutics to address health disorders linked to chronic inflammation. Founded in 2017, the company utilizes a platform that combines microbial discovery and genomics to create synergistic microbial assemblages using bacteria and fungi derived from healthy foods. Solarea Bio generates an extensive database of complete genomic sequences of these microbes and employs computational approaches to formulate combinations that exhibit strong anti-inflammatory properties. The company's therapeutics aim to prevent or mitigate health issues associated with chronic inflammation, with initial applications targeting dietary management of metabolic conditions like osteopenia and osteoporosis in postmenopausal women. Through its innovative approach, Solarea Bio seeks to enhance the quality of life by providing nature-based solutions for various health challenges.
Colossal Laboratories & Biosciences
Series B in 2023
Colossal Laboratories & Biosciences is a bioscience and genetic engineering company dedicated to addressing extinction and biodiversity loss through innovative gene editing technologies, primarily CRISPR. The company focuses on reviving extinct species, such as the woolly mammoth, while also working to protect critically endangered species and restore vital ecosystems. By employing advanced genetic techniques, Colossal aims to create solutions that not only facilitate the repopulation of ecosystems but also contribute to the sustainability of life on Earth. Through its pioneering efforts, Colossal aspires to tackle pressing environmental challenges and support the future of both ecological health and human necessities.
Dreamscape Learn
Series A in 2023
Dreamscape Learn is an edtech company focusing on cinematic story-telling, cutting-edge immersive technologies, and advanced pedagogy. They believe that the best educational designs combine multiple pedagogical modalities. Students study; they apply knowledge and concepts; they learn by doing and do in order to learn; they learn through text, lecture, visual and audio media, hands-on experience, and from one another. They create programs and products that connect all of these modes of engagement.
Syntis Bio
Venture Round in 2023
Syntis Bio is a late-stage preclinical company focused on developing a new class of therapies. The company designs innovative formulations for oral treatments that target specific tissues, thereby enhancing bioavailability. This approach aims to enable more effective interventions for patients across a broader range of diseases.
Deciduous Therapeutics
Seed Round in 2022
Deciduous Therapeutics is a biotechnology company focused on developing innovative immune-modulatory therapies aimed at addressing age-related diseases. The company specializes in creating novel molecules that activate the body's natural immune surveillance mechanisms to selectively eliminate senescent cells, which are associated with various age-related conditions. Led by Anil Bhushan, a professor at UCSF, and Robin Mansukhani, an experienced biotech entrepreneur, Deciduous Therapeutics is dedicated to promoting a healthier lifespan through its pioneering approach to therapeutics in the aging sector.
Earth Force
Seed Round in 2022
Earth Force is a developer of a forest management platform designed to prevent wildfires in forests and plantations. The company's Vegetation Management System incorporates precision GPS technology, field-based sensors for enhanced connectivity, and remote-controlled machines for efficient material handling, fire monitoring, and spot-fire suppression. Through its innovative solutions, Earth Force enables clients to effectively protect and manage forest vegetation, contributing to safer and more sustainable forestry practices.
Viome Life Sciences
Series C in 2022
Viome Life Sciences, established in 2016 and headquartered in Bellevue, Washington, specializes in providing comprehensive health insights through its proprietary at-home clinical-grade tests. The company analyzes RNA from stool samples, along with other bodily fluids, to determine the makeup of microbial communities, offering personalized recommendations for diet and lifestyle based on the results. Viome's services aim to empower individuals to track their microbiome health, mitochondrial health, cellular health, and biological age, ultimately aiding in the prevention and reversal of chronic diseases. The company operates as a subsidiary of BlueDot LLC and sells its products through distributors and online channels.
Gameto
Venture Round in 2022
Gameto is a biotechnology company focused on advancing female reproductive health through innovative therapies. Recognizing the significant lack of treatment options in this underserved area, Gameto employs cutting-edge scientific techniques to develop solutions that enhance the quality of life for women. The company utilizes cellular engineering to create a platform that produces engineered ovarian and endometrial cell lines capable of mimicking the functions of natural cells, including hormone production and response. This platform underpins a portfolio of cellular therapeutics aimed at addressing various female reproductive diseases. Gameto's first initiative, Fertilo, targets improvements in in vitro fertilization (IVF) and egg freezing processes, striving to make them shorter, safer, and more effective. Additionally, the company is developing Deovo, an organoid model of the female reproductive system, and Ameno, a cell-based therapy designed to mitigate health issues related to primary ovarian insufficiency and menopause. Through these efforts, Gameto aims to transform the landscape of female reproductive health care.
KeyCare is a virtual care platform that leverages the Epic system to support health systems in enhancing patient access and quality of care. The platform is designed to provide a tech-driven virtual care team that supplements existing healthcare workforces, thereby broadening the options available for virtual care. By focusing on increasing accessibility and improving care quality, KeyCare aims to meet the needs of patients and healthcare providers in a rapidly evolving healthcare landscape.
AliveCor, Inc. specializes in developing digital medical-grade electrocardiograms, enabling users to monitor their heart health through mobile technology. The company's flagship product, KardiaMobile, is a personal mobile EKG device that provides instant detection of common heart arrhythmias, along with features for blood pressure and weight tracking, as well as storage for recorded EKGs. Additionally, AliveCor offers KardiaMobile 6L, a six-lead EKG device that allows patients to share detailed EKG readings with healthcare providers. The company also operates KardiaCare, a digital health subscription service that empowers users to manage their heart health conveniently at home. Founded in 2010 and incorporated in 2011, AliveCor is headquartered in Mountain View, California, and is recognized for its innovative contributions to cardiac care through the integration of machine learning techniques.
Insilico Medicine
Series D in 2022
Insilico Medicine, Inc. is a biotechnology company that leverages artificial intelligence (AI) to transform drug discovery, biomarker development, and aging research. Founded in 2014 and based in Baltimore, Maryland, the company has established itself as a pioneer in applying advanced AI techniques, such as generative adversarial networks and reinforcement learning, to create novel molecular structures for various diseases, including cancer and age-related conditions. Insilico Medicine operates an integrated platform that covers all stages of drug discovery, from initial research to clinical trial analysis. Its projects include Pharma.AI, which offers machine learning services to various sectors, and Young.AI, a platform focused on aging predictors. The company also pursues internal drug discovery initiatives targeting diseases like Alzheimer's and Parkinson's, and has partnered with Life Extension to produce nutraceutical products utilizing deep learning and bioinformatics. Additionally, Insilico Medicine provides consumer applications aimed at enhancing health and longevity.
Insilico Medicine
Series D in 2022
Insilico Medicine, Inc. is a biotechnology company that leverages artificial intelligence (AI) to transform drug discovery, biomarker development, and aging research. Founded in 2014 and based in Baltimore, Maryland, the company has established itself as a pioneer in applying advanced AI techniques, such as generative adversarial networks and reinforcement learning, to create novel molecular structures for various diseases, including cancer and age-related conditions. Insilico Medicine operates an integrated platform that covers all stages of drug discovery, from initial research to clinical trial analysis. Its projects include Pharma.AI, which offers machine learning services to various sectors, and Young.AI, a platform focused on aging predictors. The company also pursues internal drug discovery initiatives targeting diseases like Alzheimer's and Parkinson's, and has partnered with Life Extension to produce nutraceutical products utilizing deep learning and bioinformatics. Additionally, Insilico Medicine provides consumer applications aimed at enhancing health and longevity.
Curebase is a company that specializes in developing software for clinical trials, aimed at enhancing the efficiency of the clinical research process. Founded in 2017 and based in San Francisco, California, Curebase offers a digital clinical trial assistant that transforms how medical providers discover, activate, and manage clinical trials for patients. The platform reduces recruitment times and automates various manual processes, allowing drug companies to distribute their trials more effectively to clinics. Additionally, it provides comprehensive data access for sponsors, enabling real-time monitoring of trial progress and data management. Curebase serves a diverse clientele, including medical device, biotech, and digital health startups, with a focus on enabling virtual studies and streamlining participant eligibility, enrollment, education, and consent.
Pyka, Inc. is a startup based in Oakland, California, that specializes in the development of autonomous electric aircraft tailored for agricultural applications and cargo transportation. Founded in 2016, the company focuses on creating innovative solutions to enhance safety, affordability, and accessibility in aviation. Pyka's aircraft are designed for complex agricultural tasks, such as precision spraying of chemicals over varied terrains, employing advanced flight controllers and onboard sensors. These fully electric planes aim to minimize environmental impact while maximizing operational efficiency, making aerial crop protection more targeted and less harmful to surrounding ecosystems. Additionally, Pyka's technology is versatile enough to facilitate cargo delivery in remote or challenging locations.
Crowdz
Convertible Note in 2022
Crowdz is a company focused on modernizing the traditional trade finance industry through innovative technology. Its invoicing software automates product search and sourcing, streamlines commercial transactions, and enhances predictive data analytics. By digitizing receivables on-chain, Crowdz enables small and midsize enterprises to access business financing, fostering their ability to compete both locally and globally. The company has auto risk-rated $4.2 billion in receivables, allowing funders to make informed decisions that align with their investment strategies. To date, over $93 million has been financed through Crowdz's platform. The firm's customer and investor base includes notable entities such as Citibank, Barclays, and Meta, contributing to its total investment of over $28 million.
Verana Networks
Series B in 2022
Verana Networks, Inc. is a technology company based in Waltham, Massachusetts, founded in 2019. It specializes in developing innovative 5G Radio Access Network solutions tailored for service providers utilizing licensed millimeter wave (mmWave) spectrum. The company’s focus on mmWave spectrum is strategic, as it represents a significant portion of new spectrum available for 5G services. Verana Networks aims to empower mobile network operators with equipment that enhances wireless connectivity, providing a substantial increase in speed and capacity essential for the success of 5G technology. This advancement not only facilitates new applications but also generates additional revenue opportunities, which are crucial for sustaining the business case for 5G deployment.
Rugged Robotics
Series A in 2022
Rugged Robotics Inc. is a Houston-based company founded in 2018 that specializes in developing robotic platforms tailored for the commercial construction industry. The company focuses on intelligent automation technologies designed to enhance productivity and efficiency on construction sites. One of its key products, the Mark I, marks architectural and engineering designs directly onto concrete floors, thereby assisting construction workers with precise layout tasks. This robotic solution not only replaces traditional manual methods, which are often slow and prone to errors, but also offers a layout-as-a-service model, enabling contractors to access these technologies without significant upfront investment. Through its innovative hardware-enabled solutions, Rugged Robotics addresses specific challenges within the construction sector, ultimately saving time and reducing costs for contractors.
ParkourSC
Venture Round in 2022
ParkourSC is a logistics and supply chain company based in Milpitas, California, founded in 2014. The company specializes in digital transformation within the manufacturing and pharmaceutical sectors. It has developed a cloud-based sensor platform that creates a digital twin of the supply chain, enabling real-time visibility into assets in motion. By processing billions of events per second, the platform provides actionable intelligence regarding the context, condition, timing, and location of materials and assets. This technology allows businesses to monitor their workflows continuously and predict potential disruptions before they occur, enhancing operational efficiency and decision-making capabilities.
Gameto is a biotechnology company focused on advancing female reproductive health through innovative therapies. Recognizing the significant lack of treatment options in this underserved area, Gameto employs cutting-edge scientific techniques to develop solutions that enhance the quality of life for women. The company utilizes cellular engineering to create a platform that produces engineered ovarian and endometrial cell lines capable of mimicking the functions of natural cells, including hormone production and response. This platform underpins a portfolio of cellular therapeutics aimed at addressing various female reproductive diseases. Gameto's first initiative, Fertilo, targets improvements in in vitro fertilization (IVF) and egg freezing processes, striving to make them shorter, safer, and more effective. Additionally, the company is developing Deovo, an organoid model of the female reproductive system, and Ameno, a cell-based therapy designed to mitigate health issues related to primary ovarian insufficiency and menopause. Through these efforts, Gameto aims to transform the landscape of female reproductive health care.
Viome Life Sciences
Series C in 2021
Viome Life Sciences, established in 2016 and headquartered in Bellevue, Washington, specializes in providing comprehensive health insights through its proprietary at-home clinical-grade tests. The company analyzes RNA from stool samples, along with other bodily fluids, to determine the makeup of microbial communities, offering personalized recommendations for diet and lifestyle based on the results. Viome's services aim to empower individuals to track their microbiome health, mitochondrial health, cellular health, and biological age, ultimately aiding in the prevention and reversal of chronic diseases. The company operates as a subsidiary of BlueDot LLC and sells its products through distributors and online channels.
MagicCube
Series C in 2021
MagicCube, Inc. is a California-based company established in 2014, specializing in secure data exchange between devices and the cloud through its Software Defined Trust platform. This innovative technology utilizes a TEE-based approach to protect user data in mobile applications, particularly in sectors such as banking and shopping. MagicCube's platform integrates seamlessly into existing applications, offering a secure solution for digital transactions across various devices, operating systems, and hardware. By providing a level of security comparable to traditional hardware solutions, the company enables businesses to safeguard against a range of cyber threats, including cloning, lifting, spoofing, and tampering, while simplifying deployment and reducing associated costs.
Meru Health
Series B in 2021
Meru Health, Inc. is a digital healthcare company based in San Mateo, California, with additional offices in Palo Alto, California, and Helsinki, Finland. Founded in 2015, it specializes in providing a mobile application that connects patients with licensed therapists through a structured 12-week program aimed at addressing mental health issues such as stress, depression, anxiety, and burnout. The platform combines continuous remote clinician support with at-home lessons and practices, including cognitive behavioral therapy and coaching in sleep and nutrition. By offering cost-effective and clinically proven digital therapeutic solutions, Meru Health empowers individuals to improve their mental well-being while also aiming to reduce overall healthcare costs.
Elevian, Inc. is a biotechnology company based in Menlo Park, California, founded in 2017. The company specializes in developing regenerative medicines aimed at preventing and treating age-related diseases. Elevian focuses on therapeutics that regulate circulating factors, particularly Growth Differentiation Factor 11 (GDF11), which are known to stimulate the regeneration of various tissues, including those in the brain, heart, pancreas, and muscle. By targeting the underlying mechanisms of aging, Elevian aims to halt and potentially reverse the molecular damage associated with aging. Its research and development efforts are directed toward conditions such as stroke recovery, Alzheimer’s disease, coronary artery disease, and Type 2 diabetes.
Curebase is a company that specializes in developing software for clinical trials, aimed at enhancing the efficiency of the clinical research process. Founded in 2017 and based in San Francisco, California, Curebase offers a digital clinical trial assistant that transforms how medical providers discover, activate, and manage clinical trials for patients. The platform reduces recruitment times and automates various manual processes, allowing drug companies to distribute their trials more effectively to clinics. Additionally, it provides comprehensive data access for sponsors, enabling real-time monitoring of trial progress and data management. Curebase serves a diverse clientele, including medical device, biotech, and digital health startups, with a focus on enabling virtual studies and streamlining participant eligibility, enrollment, education, and consent.
DocBot, Inc. is an artificial intelligence technology company based in Irvine, California, specializing in gastrointestinal diseases. The company develops web-based applications for iOS and Android devices that serve as a clinical decision support system, aggregating patient information and providing cloud analytics to healthcare professionals. Its flagship product is built on the UltivisionAI software platform, which offers real-time image analysis, automated reporting, and analytical tools aimed at enhancing patient care and clinical workflows. By integrating various data sources from imaging systems to pathology requisitions, DocBot's platform aids physicians in detecting colorectal cancer and other gastrointestinal conditions, ultimately striving to improve healthcare outcomes and reduce patient risks.
Chef Robotics
Seed Round in 2021
Chef Robotics is a robotics and artificial intelligence company serving the food industry. The company was founded in 2019 and is headquartered in San Francisco, California.
SeQure DX
Venture Round in 2021
SeQure DX is a biotechnology company specializing in genomics diagnostics for CRISPR-based gene editing therapies. It develops technologies that identify potential off-target sites prior to therapy initiation, ensuring comprehensive confirmation of actual edits. This enables safer and more effective gene editing therapeutics development, benefiting both researchers and patients.
Bionaut Labs
Series A in 2021
Bionaut Labs, established in 2016 and based in Palo Alto, California, specializes in the design, manufacture, and control of intra-tissue navigation platforms. The company's core technology involves nano/micro robots, dubbed 'Bionauts', which operate within the body to deliver treatments with anatomical precision. Bionaut Labs aims to revolutionize the treatment of central nervous system disorders by enabling new therapeutic technologies like gene therapy and CRISPR-Cas9 in challenging clinical settings. Their remote-controlled micro-robots allow for precise targeting, tracking, and payload release, potentially automating complex surgeries remotely without external incisions.
Mighty Buildings
Series B in 2021
Mighty Buildings, Inc. is a San Francisco-based company founded in 2017 that specializes in the manufacture of 3D printed custom homes. Utilizing advanced construction technology, the company employs 3D printing, robotics, and automation to create modular homes that aim to disrupt the residential housing market. Mighty Buildings has developed a proprietary building material known as Light Stone Material (LSM), which mimics synthetic stone and provides advantages such as faster construction, zero waste, and improved thermal regulation compared to traditional materials like concrete, wood, or steel. The company's innovative approach focuses on producing prefabricated, environmentally friendly, and climate-resilient homes, thereby facilitating smart urban development and making housing more affordable.
Crowdz is a company focused on modernizing the traditional trade finance industry through innovative technology. Its invoicing software automates product search and sourcing, streamlines commercial transactions, and enhances predictive data analytics. By digitizing receivables on-chain, Crowdz enables small and midsize enterprises to access business financing, fostering their ability to compete both locally and globally. The company has auto risk-rated $4.2 billion in receivables, allowing funders to make informed decisions that align with their investment strategies. To date, over $93 million has been financed through Crowdz's platform. The firm's customer and investor base includes notable entities such as Citibank, Barclays, and Meta, contributing to its total investment of over $28 million.
Elevian
Venture Round in 2020
Elevian, Inc. is a biotechnology company based in Menlo Park, California, founded in 2017. The company specializes in developing regenerative medicines aimed at preventing and treating age-related diseases. Elevian focuses on therapeutics that regulate circulating factors, particularly Growth Differentiation Factor 11 (GDF11), which are known to stimulate the regeneration of various tissues, including those in the brain, heart, pancreas, and muscle. By targeting the underlying mechanisms of aging, Elevian aims to halt and potentially reverse the molecular damage associated with aging. Its research and development efforts are directed toward conditions such as stroke recovery, Alzheimer’s disease, coronary artery disease, and Type 2 diabetes.
AliveCor, Inc. specializes in developing digital medical-grade electrocardiograms, enabling users to monitor their heart health through mobile technology. The company's flagship product, KardiaMobile, is a personal mobile EKG device that provides instant detection of common heart arrhythmias, along with features for blood pressure and weight tracking, as well as storage for recorded EKGs. Additionally, AliveCor offers KardiaMobile 6L, a six-lead EKG device that allows patients to share detailed EKG readings with healthcare providers. The company also operates KardiaCare, a digital health subscription service that empowers users to manage their heart health conveniently at home. Founded in 2010 and incorporated in 2011, AliveCor is headquartered in Mountain View, California, and is recognized for its innovative contributions to cardiac care through the integration of machine learning techniques.
Solarea Bio
Series A in 2020
Solarea Bio, Inc. is a biotechnology company based in Cambridge, Massachusetts, focused on developing microbial therapeutics to address health disorders linked to chronic inflammation. Founded in 2017, the company utilizes a platform that combines microbial discovery and genomics to create synergistic microbial assemblages using bacteria and fungi derived from healthy foods. Solarea Bio generates an extensive database of complete genomic sequences of these microbes and employs computational approaches to formulate combinations that exhibit strong anti-inflammatory properties. The company's therapeutics aim to prevent or mitigate health issues associated with chronic inflammation, with initial applications targeting dietary management of metabolic conditions like osteopenia and osteoporosis in postmenopausal women. Through its innovative approach, Solarea Bio seeks to enhance the quality of life by providing nature-based solutions for various health challenges.
Symbiome
Venture Round in 2020
Symbiome, Inc. is a skincare company based in San Francisco, California, that develops and sells products formulated with microbiomic and plant-based ingredients. Founded in 2017, the company aims to provide effective skincare solutions using scientifically and intentionally formulated ancestral ingredients, eschewing modern chemical additives. By focusing on natural formulations, Symbiome seeks to enhance skin clarity, vibrance, and resilience, offering customers organic alternatives for their skincare needs. The company, which was formerly known as Persona Biome, Inc., rebranded in December 2019 to reflect its commitment to holistic and nature-inspired skincare.
Deep Longevity
Series A in 2020
Deep Longevity, Inc. is a biotechnology company focused on developing innovative solutions for aging and longevity. Founded in 2016 and based in Hong Kong, the company specializes in creating aging and longevity clocks tailored for preventative medicine organizations, health clubs, insurance companies, and aging centers. Its offerings include Longevity Cloud, a platform that hosts deep aging clocks, and Young.AI, a web and mobile application designed to support longevity initiatives. Deep Longevity also develops multifactorial tools known as deep aging clocks to measure biological age, alongside a recommendation engine aimed at suggesting longevity interventions. The company employs advanced AI techniques to harness various data types, including clinical blood tests and other biological metrics, to enhance the accuracy of biological age predictions.
Proprio, Inc. is a healthcare technology company based in Seattle, Washington, that focuses on developing an advanced surgical navigation and imaging platform. Founded in 2016, the company utilizes machine learning, artificial intelligence, and mixed-reality user interfaces to enhance surgical accuracy and simplify workflows, ultimately improving patient outcomes. Proprio's innovative solutions aim to replace traditional surgical microscopes and navigation systems with a more integrated system that leverages networked camera arrays, depth-sensing technology, and computer graphics. By synthesizing data from multiple inputs, Proprio enables medical professionals to navigate complex anatomical structures in real-time 3D environments, fostering a shift in medicine that embraces modern technological advancements. The company's vision extends beyond mere replacement of existing tools; it seeks to transform the surgical landscape by integrating software and data-driven approaches, enhancing the collaboration between humans and machines in the operating room.
MagicCube
Series B in 2020
MagicCube, Inc. is a California-based company established in 2014, specializing in secure data exchange between devices and the cloud through its Software Defined Trust platform. This innovative technology utilizes a TEE-based approach to protect user data in mobile applications, particularly in sectors such as banking and shopping. MagicCube's platform integrates seamlessly into existing applications, offering a secure solution for digital transactions across various devices, operating systems, and hardware. By providing a level of security comparable to traditional hardware solutions, the company enables businesses to safeguard against a range of cyber threats, including cloning, lifting, spoofing, and tampering, while simplifying deployment and reducing associated costs.
Gali Health
Seed Round in 2020
Gali Health, Inc. is a health technology company based in San Francisco, California, founded in 2015. The company has developed a mobile application called Gali, which serves as a personal health assistant aimed at individuals with chronic conditions. Gali leverages collective intelligence and artificial intelligence to analyze health data, providing users with personalized support regarding medical, lifestyle, and psychological aspects of managing their health. The platform focuses on empowering users by crowdsourcing health information and delivering medically-validated insights, enabling proactive health management. Gali Health's mission is to ensure that individuals dealing with chronic illnesses do not feel isolated or powerless, advancing consumer-driven healthcare through innovative technology.
Meru Health
Series A in 2020
Meru Health, Inc. is a digital healthcare company based in San Mateo, California, with additional offices in Palo Alto, California, and Helsinki, Finland. Founded in 2015, it specializes in providing a mobile application that connects patients with licensed therapists through a structured 12-week program aimed at addressing mental health issues such as stress, depression, anxiety, and burnout. The platform combines continuous remote clinician support with at-home lessons and practices, including cognitive behavioral therapy and coaching in sleep and nutrition. By offering cost-effective and clinically proven digital therapeutic solutions, Meru Health empowers individuals to improve their mental well-being while also aiming to reduce overall healthcare costs.
Chef Robotics
Seed Round in 2020
Chef Robotics is a robotics and artificial intelligence company serving the food industry. The company was founded in 2019 and is headquartered in San Francisco, California.
Pyka, Inc. is a startup based in Oakland, California, that specializes in the development of autonomous electric aircraft tailored for agricultural applications and cargo transportation. Founded in 2016, the company focuses on creating innovative solutions to enhance safety, affordability, and accessibility in aviation. Pyka's aircraft are designed for complex agricultural tasks, such as precision spraying of chemicals over varied terrains, employing advanced flight controllers and onboard sensors. These fully electric planes aim to minimize environmental impact while maximizing operational efficiency, making aerial crop protection more targeted and less harmful to surrounding ecosystems. Additionally, Pyka's technology is versatile enough to facilitate cargo delivery in remote or challenging locations.
GuRu Wireless, Inc. enables safe, effective and customizable transmission of power over-the-air using proprietary millimeter-wave (mmWave) integrated circuits, modules and proprietary Smart RF Lensing technology. A miniature-sized power transfer system delivers power at an unprecedented distance efficiently and with precision. GuRu's wireless solution can be used as a charging hub or a power source in many settings where access to an energy source is needed. It is easy to install, safe, and sophisticated enough to find and adjust for various power levels to sync with the needs of any device. Even during use, it continuously charges devices and as a safety measure, reroutes power as necessary. Founded in 2017 by a team of scientists and engineers from Caltech, GuRu aims to ensure access to power be as ubiquitous as WiFi.
Metawave Corporation is a technology company based in Palo Alto, California, specializing in the development of advanced beamsteering radars using metamaterials and artificial intelligence. Founded in 2017, the company primarily serves the automotive industry, offering innovative solutions for safe automated driving. Its flagship product, SPEKTRA, is designed to enhance safety for automakers by providing high-performance radar capabilities for 3D imaging and vehicle-to-vehicle communications. Additionally, Metawave develops TURBO active repeaters to extend signal coverage in difficult environments, as well as ECHO passive reflectors to optimize signal direction in areas with lower coverage. The company also offers AWARE, an AI platform that leverages deep learning to extract valuable information from radar signals. In parallel, Metawave is working on smart beamsteering antennas to improve 4G and 5G networks, aiming to enhance connectivity for billions of users.
Insilico Medicine
Series B in 2019
Insilico Medicine, Inc. is a biotechnology company that leverages artificial intelligence (AI) to transform drug discovery, biomarker development, and aging research. Founded in 2014 and based in Baltimore, Maryland, the company has established itself as a pioneer in applying advanced AI techniques, such as generative adversarial networks and reinforcement learning, to create novel molecular structures for various diseases, including cancer and age-related conditions. Insilico Medicine operates an integrated platform that covers all stages of drug discovery, from initial research to clinical trial analysis. Its projects include Pharma.AI, which offers machine learning services to various sectors, and Young.AI, a platform focused on aging predictors. The company also pursues internal drug discovery initiatives targeting diseases like Alzheimer's and Parkinson's, and has partnered with Life Extension to produce nutraceutical products utilizing deep learning and bioinformatics. Additionally, Insilico Medicine provides consumer applications aimed at enhancing health and longevity.
ParkourSC
Series B in 2019
ParkourSC is a logistics and supply chain company based in Milpitas, California, founded in 2014. The company specializes in digital transformation within the manufacturing and pharmaceutical sectors. It has developed a cloud-based sensor platform that creates a digital twin of the supply chain, enabling real-time visibility into assets in motion. By processing billions of events per second, the platform provides actionable intelligence regarding the context, condition, timing, and location of materials and assets. This technology allows businesses to monitor their workflows continuously and predict potential disruptions before they occur, enhancing operational efficiency and decision-making capabilities.
Mighty Buildings
Series A in 2019
Mighty Buildings, Inc. is a San Francisco-based company founded in 2017 that specializes in the manufacture of 3D printed custom homes. Utilizing advanced construction technology, the company employs 3D printing, robotics, and automation to create modular homes that aim to disrupt the residential housing market. Mighty Buildings has developed a proprietary building material known as Light Stone Material (LSM), which mimics synthetic stone and provides advantages such as faster construction, zero waste, and improved thermal regulation compared to traditional materials like concrete, wood, or steel. The company's innovative approach focuses on producing prefabricated, environmentally friendly, and climate-resilient homes, thereby facilitating smart urban development and making housing more affordable.
Gallant Pet
Series A in 2019
Gallant Pet, Inc. is a pet service company based in San Diego, California, that specializes in stem cell preservation services for pets. Founded in 2018 by Aaron Hirschhorn, the company collects and banks stem cells from tissue during routine spay or neuter procedures. Gallant Pet also provides a platelet-rich plasma (PRP) kit for treatment of dogs suffering from osteoarthritis or other musculoskeletal conditions. In addition to its preservation services, Gallant Pet is involved in clinical research to develop effective stem cell therapies for pets. The company's focus on retrieving and preserving regenerative cells allows pet owners to utilize their pets' young stem cells for potential treatments when needed.
Gali Health
Seed Round in 2019
Gali Health, Inc. is a health technology company based in San Francisco, California, founded in 2015. The company has developed a mobile application called Gali, which serves as a personal health assistant aimed at individuals with chronic conditions. Gali leverages collective intelligence and artificial intelligence to analyze health data, providing users with personalized support regarding medical, lifestyle, and psychological aspects of managing their health. The platform focuses on empowering users by crowdsourcing health information and delivering medically-validated insights, enabling proactive health management. Gali Health's mission is to ensure that individuals dealing with chronic illnesses do not feel isolated or powerless, advancing consumer-driven healthcare through innovative technology.
Viome Life Sciences
Series B in 2019
Viome Life Sciences, established in 2016 and headquartered in Bellevue, Washington, specializes in providing comprehensive health insights through its proprietary at-home clinical-grade tests. The company analyzes RNA from stool samples, along with other bodily fluids, to determine the makeup of microbial communities, offering personalized recommendations for diet and lifestyle based on the results. Viome's services aim to empower individuals to track their microbiome health, mitochondrial health, cellular health, and biological age, ultimately aiding in the prevention and reversal of chronic diseases. The company operates as a subsidiary of BlueDot LLC and sells its products through distributors and online channels.
Mojo Vision
Series B in 2019
Mojo Vision Inc. is a technology company based in Saratoga, California, founded in 2015. The company specializes in the development of augmented reality solutions, focusing on high-performance micro-LED display technology. Mojo Vision has created the world's smallest and densest dynamic display for smart contact lenses, which are designed to provide users with timely information seamlessly and hands-free, without the distractions associated with traditional mobile devices. The company is also engaged in a joint development agreement with Menicon Co., Ltd. to explore smart contact lens products, further enhancing its innovative offerings. By combining advanced display and semiconductor expertise with proprietary quantum-dot technology, Mojo Vision aims to revolutionize the display industry, addressing diverse applications across consumer, enterprise, and government sectors.
DocBot, Inc. is an artificial intelligence technology company based in Irvine, California, specializing in gastrointestinal diseases. The company develops web-based applications for iOS and Android devices that serve as a clinical decision support system, aggregating patient information and providing cloud analytics to healthcare professionals. Its flagship product is built on the UltivisionAI software platform, which offers real-time image analysis, automated reporting, and analytical tools aimed at enhancing patient care and clinical workflows. By integrating various data sources from imaging systems to pathology requisitions, DocBot's platform aids physicians in detecting colorectal cancer and other gastrointestinal conditions, ultimately striving to improve healthcare outcomes and reduce patient risks.
Iota Biosciences
Series A in 2018
Iota Biosciences, Inc. is a medical device company based in Berkeley, California, founded in 2017. The company specializes in developing innovative bioelectronic devices that utilize wireless sensors to monitor, measure, and stimulate internal nerves, muscles, and organs for electroceutical applications aimed at treating immune and neural disorders. Iota's technology is built on pioneering ultrasound advancements from the University of California, Berkeley, and includes implantable, mote-sized ultrasonic sensors that facilitate completely wireless neural recordings. This approach eliminates the need for tethered connections, allowing for real-time monitoring and improved treatment of diseases. As a subsidiary of Astellas Pharma Inc., Iota Biosciences is committed to delivering safe and effective diagnostic and therapeutic solutions that transform disease management and significantly enhance patient care.
Octi is the world’s first augmented reality social platform where reality merges with the metaverse and empowers anyone to create vibrant content with digital objects and scenes, rewarding creators with virtual and physical goods from leading brands. Octi’s independent Los Angeles-based team builds and combines the latest in machine learning, computer vision, and AR technologies to deliver the killer applications of the future.
Insilico Medicine
Series A in 2018
Insilico Medicine, Inc. is a biotechnology company that leverages artificial intelligence (AI) to transform drug discovery, biomarker development, and aging research. Founded in 2014 and based in Baltimore, Maryland, the company has established itself as a pioneer in applying advanced AI techniques, such as generative adversarial networks and reinforcement learning, to create novel molecular structures for various diseases, including cancer and age-related conditions. Insilico Medicine operates an integrated platform that covers all stages of drug discovery, from initial research to clinical trial analysis. Its projects include Pharma.AI, which offers machine learning services to various sectors, and Young.AI, a platform focused on aging predictors. The company also pursues internal drug discovery initiatives targeting diseases like Alzheimer's and Parkinson's, and has partnered with Life Extension to produce nutraceutical products utilizing deep learning and bioinformatics. Additionally, Insilico Medicine provides consumer applications aimed at enhancing health and longevity.
Oura is a Finnish company that specializes in the development of a smart wellness ring designed to monitor and track various biometric data related to health and well-being. The ring incorporates advanced sensors to measure key metrics such as heart rate, sleep cycles, and activity levels, providing users with insights into their physiological and behavioral responses to sleep, rest, and recovery. This data is accessible through the accompanying Oura application, which enables users to understand their overall health status and make informed lifestyle choices. Oura operates within the health and wellness industry, focusing on enhancing the user's understanding of their body and promoting better health outcomes.
IVIVA Medical, Inc. is a biotechnology company based in Beverly, Massachusetts, focused on developing innovative therapies for end-stage renal disease (ESRD). Founded in 2013, the company aims to address the critical shortage of donor organs by creating autologous tissue constructs that provide alternative treatments for patients suffering from this condition, which affects over 500,000 individuals in the United States. IVIVA Medical leverages advanced technologies in tissue engineering, 3D additive manufacturing, and stem cell biology to create bioartificial platforms and systems. These platforms not only facilitate therapeutic applications but also serve as essential building blocks for the next generation of engineered, functionalized tissues, positioning IVIVA Medical at the forefront of regenerative medicine and enhancing the capacity of medical professionals to manage end-stage kidney disease.
Synadia
Seed Round in 2018
Synadia Communications Inc. is a technology company based in Los Angeles, California, founded in 2017. It specializes in developing a global utility platform that connects digital systems, services, and devices. The company is known for its open-source messaging system, NATS.io, which supports cloud-native applications, microservices architectures, and Internet of Things (IoT) messaging. Synadia leads the development of NATS.io as a Cloud Native Computing Foundation (CNCF) project and offers a secure, globally available communications platform known as NGS, built on this technology. In addition to its core offerings, Synadia provides commercial support, consulting, non-recurring engineering (NRE) services, and training, enabling organizations to leverage its innovative solutions for modern distributed systems.
Elevian
Convertible Note in 2018
Elevian, Inc. is a biotechnology company based in Menlo Park, California, founded in 2017. The company specializes in developing regenerative medicines aimed at preventing and treating age-related diseases. Elevian focuses on therapeutics that regulate circulating factors, particularly Growth Differentiation Factor 11 (GDF11), which are known to stimulate the regeneration of various tissues, including those in the brain, heart, pancreas, and muscle. By targeting the underlying mechanisms of aging, Elevian aims to halt and potentially reverse the molecular damage associated with aging. Its research and development efforts are directed toward conditions such as stroke recovery, Alzheimer’s disease, coronary artery disease, and Type 2 diabetes.
Exo is a medical device startup focused on revolutionizing ultrasound technology for imaging and therapeutic applications. The company has developed a handheld ultrasound platform that integrates advanced nano-materials, innovative sensor technologies, and sophisticated signal processing with the cost advantages of semiconductor manufacturing. This approach allows Exo to provide high-quality, affordable, and user-friendly medical imaging solutions. By enabling healthcare professionals to make critical, real-time decisions, Exo aims to enhance patient outcomes significantly. The company's commitment to accessibility and ease of use in medical imaging represents a significant advancement in the field, making effective diagnostic tools available at an unprecedented price point.
Atomiton
Seed Round in 2017
Atomiton is a developer of industrial software aimed at transforming and optimizing operations on a global scale. The company's platform utilizes artificial intelligence and machine learning to enhance operational efficiencies and conduct real-time industrial analytics. By offering insights into carbon emissions and energy consumption, Atomiton enables businesses to monitor and improve their sustainability metrics. This capability allows organizations to reduce costs while simultaneously minimizing their operational energy, water, and carbon intensity, ultimately supporting their goals for sustainability and efficiency.
Dreamscape Immersive
Series B in 2017
Dreamscape Immersive, Inc. is a company that specializes in developing location-based virtual reality software to create a new genre of mainstream entertainment. Founded in 2016 and based in Culver City, California, it offers a unique product known as Dreamscape, which merges the emotional impact of cinematic storytelling with the excitement of theme-park attractions. This innovative approach allows users to experience immersive stories in a social setting, making it possible for friends and families to share the wonder of virtual reality together. Dreamscape Immersive operates in various locations, including Los Angeles, Dallas, Columbus, and Dubai, providing audiences with access to both original and franchised virtual experiences.
ParkourSC
Series A in 2017
ParkourSC is a logistics and supply chain company based in Milpitas, California, founded in 2014. The company specializes in digital transformation within the manufacturing and pharmaceutical sectors. It has developed a cloud-based sensor platform that creates a digital twin of the supply chain, enabling real-time visibility into assets in motion. By processing billions of events per second, the platform provides actionable intelligence regarding the context, condition, timing, and location of materials and assets. This technology allows businesses to monitor their workflows continuously and predict potential disruptions before they occur, enhancing operational efficiency and decision-making capabilities.
GuRu Wireless, Inc. enables safe, effective and customizable transmission of power over-the-air using proprietary millimeter-wave (mmWave) integrated circuits, modules and proprietary Smart RF Lensing technology. A miniature-sized power transfer system delivers power at an unprecedented distance efficiently and with precision. GuRu's wireless solution can be used as a charging hub or a power source in many settings where access to an energy source is needed. It is easy to install, safe, and sophisticated enough to find and adjust for various power levels to sync with the needs of any device. Even during use, it continuously charges devices and as a safety measure, reroutes power as necessary. Founded in 2017 by a team of scientists and engineers from Caltech, GuRu aims to ensure access to power be as ubiquitous as WiFi.
Metawave
Seed Round in 2017
Metawave Corporation is a technology company based in Palo Alto, California, specializing in the development of advanced beamsteering radars using metamaterials and artificial intelligence. Founded in 2017, the company primarily serves the automotive industry, offering innovative solutions for safe automated driving. Its flagship product, SPEKTRA, is designed to enhance safety for automakers by providing high-performance radar capabilities for 3D imaging and vehicle-to-vehicle communications. Additionally, Metawave develops TURBO active repeaters to extend signal coverage in difficult environments, as well as ECHO passive reflectors to optimize signal direction in areas with lower coverage. The company also offers AWARE, an AI platform that leverages deep learning to extract valuable information from radar signals. In parallel, Metawave is working on smart beamsteering antennas to improve 4G and 5G networks, aiming to enhance connectivity for billions of users.
Pyka
Pre Seed Round in 2017
Pyka, Inc. is a startup based in Oakland, California, that specializes in the development of autonomous electric aircraft tailored for agricultural applications and cargo transportation. Founded in 2016, the company focuses on creating innovative solutions to enhance safety, affordability, and accessibility in aviation. Pyka's aircraft are designed for complex agricultural tasks, such as precision spraying of chemicals over varied terrains, employing advanced flight controllers and onboard sensors. These fully electric planes aim to minimize environmental impact while maximizing operational efficiency, making aerial crop protection more targeted and less harmful to surrounding ecosystems. Additionally, Pyka's technology is versatile enough to facilitate cargo delivery in remote or challenging locations.
MagicCube
Series A in 2017
MagicCube, Inc. is a California-based company established in 2014, specializing in secure data exchange between devices and the cloud through its Software Defined Trust platform. This innovative technology utilizes a TEE-based approach to protect user data in mobile applications, particularly in sectors such as banking and shopping. MagicCube's platform integrates seamlessly into existing applications, offering a secure solution for digital transactions across various devices, operating systems, and hardware. By providing a level of security comparable to traditional hardware solutions, the company enables businesses to safeguard against a range of cyber threats, including cloning, lifting, spoofing, and tampering, while simplifying deployment and reducing associated costs.
Viome Life Sciences
Series A in 2017
Viome Life Sciences, established in 2016 and headquartered in Bellevue, Washington, specializes in providing comprehensive health insights through its proprietary at-home clinical-grade tests. The company analyzes RNA from stool samples, along with other bodily fluids, to determine the makeup of microbial communities, offering personalized recommendations for diet and lifestyle based on the results. Viome's services aim to empower individuals to track their microbiome health, mitochondrial health, cellular health, and biological age, ultimately aiding in the prevention and reversal of chronic diseases. The company operates as a subsidiary of BlueDot LLC and sells its products through distributors and online channels.
Exo is a medical device startup focused on revolutionizing ultrasound technology for imaging and therapeutic applications. The company has developed a handheld ultrasound platform that integrates advanced nano-materials, innovative sensor technologies, and sophisticated signal processing with the cost advantages of semiconductor manufacturing. This approach allows Exo to provide high-quality, affordable, and user-friendly medical imaging solutions. By enabling healthcare professionals to make critical, real-time decisions, Exo aims to enhance patient outcomes significantly. The company's commitment to accessibility and ease of use in medical imaging represents a significant advancement in the field, making effective diagnostic tools available at an unprecedented price point.
Dreamscape Immersive
Series A in 2017
Dreamscape Immersive, Inc. is a company that specializes in developing location-based virtual reality software to create a new genre of mainstream entertainment. Founded in 2016 and based in Culver City, California, it offers a unique product known as Dreamscape, which merges the emotional impact of cinematic storytelling with the excitement of theme-park attractions. This innovative approach allows users to experience immersive stories in a social setting, making it possible for friends and families to share the wonder of virtual reality together. Dreamscape Immersive operates in various locations, including Los Angeles, Dallas, Columbus, and Dubai, providing audiences with access to both original and franchised virtual experiences.
DigiLens Inc. is a technology company based in Sunnyvale, California, specializing in holographic waveguide display solutions for extended reality (XR) applications. Founded in 1997 and formerly known as SBG Labs, DigiLens has developed a patented optical platform and photopolymer technology that enables original equipment manufacturers (OEMs) to create customizable XR devices for various sectors, including automotive, enterprise, consumer, avionics, and military. The company offers a range of products, such as the Crystal30 and Crystal50 lenses, which facilitate the design of waveguide-based displays. Additionally, DigiLens provides innovative solutions like the DigiLens AutoHUD, which enhances the field of view of traditional heads-up displays, and CrystalClear, an augmented reality heads-up display. Supporting its offerings, DigiLens also supplies light engines and hardware development kits, such as Insight30, to assist users in developing wearable devices.
Terramera
Venture Round in 2016
Terramera, founded in 2009 and based in Vancouver, Canada, specializes in developing and manufacturing plant-based pesticides and fertilizers as alternatives to conventional chemical products. The company offers solutions such as Proof for bed bug and dust mite control, Actigate as an organic pesticide, and Rango for pest control and crop protection. Terramera's technology platforms integrate artificial intelligence, science, and nature to promote sustainable farming practices, aiming to create a healthy and safe environment free from toxic chemicals. This approach supports farmers in achieving improved yields and profits through organic and sustainable methods.
Epharmix
Seed Round in 2016
Epharmix, Inc. is a digital healthcare company that specializes in developing clinically validated, condition-specific communication tools designed for the healthcare industry. Founded in 2015 and based in St. Louis, Missouri, the company creates digital interventions tailored to various patient populations, aimed at enhancing patient-physician engagement. Epharmix's products facilitate the automatic collection of clinical data over time, which allows for algorithmic alerts to healthcare providers, thereby supporting chronic care management for patients. By focusing on underserved patient groups, Epharmix enables care teams to improve healthcare delivery while reducing workload through proven interventions that enhance both engagement and health outcomes.
Meta View
Series B in 2016
Meta View is a technology company specializing in augmented and virtual reality solutions, catering to various industries such as manufacturing, communication, media, medicine, education, and 3D modeling. Founded in 2019 by Ben Sand, Meron Gribetz, and Raymond Lo, the company develops wearable devices and development kits, including the Meta 1 and Meta 2, which enable users to interact with holograms and access digital information seamlessly. Headquartered in San Mateo, California, Meta View distributes its products to markets in the United States, Canada, Australia, New Zealand, Hong Kong, Japan, Singapore, Taiwan, and throughout the European Union and EFTA. The company's innovative offerings leverage machine learning and artificial intelligence to enhance user experiences in both augmented and virtual reality environments.
Terramera
Venture Round in 2016
Terramera, founded in 2009 and based in Vancouver, Canada, specializes in developing and manufacturing plant-based pesticides and fertilizers as alternatives to conventional chemical products. The company offers solutions such as Proof for bed bug and dust mite control, Actigate as an organic pesticide, and Rango for pest control and crop protection. Terramera's technology platforms integrate artificial intelligence, science, and nature to promote sustainable farming practices, aiming to create a healthy and safe environment free from toxic chemicals. This approach supports farmers in achieving improved yields and profits through organic and sustainable methods.
Singularity University
Series A in 2016
Singularity University, officially known as Singularity Education Group, is a benefit corporation based in Santa Clara, California, founded in 2008. It operates as a learning and innovation community that collaborates with entrepreneurs, corporations, nonprofits, governments, investors, and academic institutions. The organization provides a range of educational programs, including executive and exponential innovation programs, an incubator, and a global startup program. Its offerings encompass online courses focused on exponential thinking and behavioral transformation, as well as international summits and events aimed at fostering collaboration and innovation. Singularity University aims to equip individuals and organizations with the knowledge and tools to leverage advanced technologies such as artificial intelligence, robotics, and biotechnology to address significant global challenges like education, health, and environmental sustainability. Through its global network, which includes numerous chapters and alumni, Singularity University seeks to inspire and empower individuals to create impactful solutions that benefit humanity.
BlueDot is a venture capital firm that specializes in commercializing cutting-edge technologies originating from NASA and national laboratories. Its mission is to identify radical technological breakthroughs in these institutions and foster them by pairing them with skilled entrepreneurs. The company focuses on innovations that have the potential to address global challenges and improve lives on a large scale. BlueDot's competitive advantage lies in its ability to combine entrepreneurial expertise with groundbreaking scientific research and unique market insights.
BlueLine Grid
Venture Round in 2016
BlueLine Grid, Inc. is a provider of mobile solutions that connects law enforcement, first responders, security teams, and government agencies across the United States. Founded in 2013 and headquartered in Annapolis, Maryland, the company offers a suite of secure communication tools designed to meet the needs of public and private security officials. Its flagship product, GridTeam, is a mobile application that allows users to locate and connect with one another based on area, organization, proximity, or specialty. Additionally, BlueLine Grid features a Grid bot for Microsoft Skype, enabling mass notification services and group conferencing directly from Skype messages. The company's services prioritize security and privacy, catering to the collaboration needs of demanding government agencies and leading corporations.
CloudMondo
Venture Round in 2016
CloudMondo is a technology startup based in Silicon Valley that operates an online marketplace for Over-The-Top (OTT) network services. The company aims to make internet connectivity a fundamental right by providing a cloud-based platform designed to offer disruptively affordable broadband access. Its patent-pending platform utilizes artificial intelligence, open-source technologies, virtualization, and software-defined networking to significantly lower the costs and complexities associated with delivering reliable internet services. CloudMondo also offers a suite of high-value OTT services that can be tailored for various stakeholders, including municipalities, venue owners, service providers, and businesses, enabling them to generate revenue while enhancing broadband access for their users. The platform has successfully entered production and is currently operational in twelve countries across four continents, reflecting its commitment to improving global internet accessibility.
Kindred AI
Series A in 2015
Kindred's mission is to build machines with human-like intelligence. Since its founding in 2014, Kindred has been exploring and engineering systems that enable robots to interact with the physical world, fulfilling the goal of bringing humans and intelligent machines together to solve real-world problems. Kindred has built an AI platform that integrates vision, grasping and placement to create autonomous solutions for complex commercial problems. With increased labor complexities in e-commerce fulfillment centers, Kindred developed a flagship product, SORT, to help retailers stay competitive. Kindred smart piece-picking SORT robots tackle a labor intensive part of the supply chain, which is Putwall Sortation, completing the manual task to pick and place items into separate customer orders. Kindred robots are currently in commercial use at e-commerce leaders including Gap, Inc., Carter’s and other global retailers. The Kindred SORT robots work alongside warehouse staff to quickly and accurately sort items into individual customer orders. Kindred has offices in San Francisco & Toronto.
Meta View
Series A in 2015
Meta View is a technology company specializing in augmented and virtual reality solutions, catering to various industries such as manufacturing, communication, media, medicine, education, and 3D modeling. Founded in 2019 by Ben Sand, Meron Gribetz, and Raymond Lo, the company develops wearable devices and development kits, including the Meta 1 and Meta 2, which enable users to interact with holograms and access digital information seamlessly. Headquartered in San Mateo, California, Meta View distributes its products to markets in the United States, Canada, Australia, New Zealand, Hong Kong, Japan, Singapore, Taiwan, and throughout the European Union and EFTA. The company's innovative offerings leverage machine learning and artificial intelligence to enhance user experiences in both augmented and virtual reality environments.
ParkourSC
Seed Round in 2014
ParkourSC is a logistics and supply chain company based in Milpitas, California, founded in 2014. The company specializes in digital transformation within the manufacturing and pharmaceutical sectors. It has developed a cloud-based sensor platform that creates a digital twin of the supply chain, enabling real-time visibility into assets in motion. By processing billions of events per second, the platform provides actionable intelligence regarding the context, condition, timing, and location of materials and assets. This technology allows businesses to monitor their workflows continuously and predict potential disruptions before they occur, enhancing operational efficiency and decision-making capabilities.
AliveCor, Inc. specializes in developing digital medical-grade electrocardiograms, enabling users to monitor their heart health through mobile technology. The company's flagship product, KardiaMobile, is a personal mobile EKG device that provides instant detection of common heart arrhythmias, along with features for blood pressure and weight tracking, as well as storage for recorded EKGs. Additionally, AliveCor offers KardiaMobile 6L, a six-lead EKG device that allows patients to share detailed EKG readings with healthcare providers. The company also operates KardiaCare, a digital health subscription service that empowers users to manage their heart health conveniently at home. Founded in 2010 and incorporated in 2011, AliveCor is headquartered in Mountain View, California, and is recognized for its innovative contributions to cardiac care through the integration of machine learning techniques.